Emkay
MHL’s Q3FY25 EBITDA missed street/our estimates by 9%/4%, with revenue growing 11% YoY driven by B2C revenue improving 15% YoY.
Metropolis Healthcare Ltd. is trading at high day volume of 323.4K.
More from Metropolis Healthcare Ltd.
Recommended